Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Clinical trial NCT07007065 · RECRUITING
Trial details
- NCT number
- NCT07007065
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2033-03-01
- Enrollment
- 561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.